Stage IV cancer patients and psilocybin - Patient Interviews
Main Category: Cancer / OncologyArticle Date: 30 Sep 2004 - 0:00 PDT
email to a friend
printer friendly
opinions'Stage IV cancer patients and psilocybin - Patient Interviews'
| Patient / Public: |  |
|
| Healthcare Prof: |  |
4.6 (10 votes) |
Stage IV cancer patients who suffer from anxiety may want to investigate a new research study recently approved by the Food and Drug Administration (FDA) taking place at LA BioMed. The specific aim of the study is to learn whether the psychoactive drug, psilocybin, might be effective in reducing anxiety, depression and physical pain, and therefore improving quality of life for Stage IV cancer patients.
Psilocybin is a novel agent that produces a profound alteration in your state of consciousness. To speak to a patient who went through this clinical trial, contact David Feuerherd at 310-215-0234. For more information on the trial, call Charles S. Grob, MD, at 310-222-3175.
The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) is one of the largest independent, not-for-profit biomedical research institutes in Los Angeles County. Affiliated with both the David Geffen School of Medicine at UCLA and the Harbor-UCLA Medical Center, the Institute has an annual budget of over $67 million and currently supports more than 1,000 research studies in areas such as cardiology, emerging infections, cancer, women's health, reproductive health, vaccine research, respiratory physiology, neonatology, molecular biology, and genetics.
LA BioMed also plays a pivotal role in the training of young physician - scientists and scientists-to-be and is active in promoting the health and well being of nearby communities through community service programs that meet a variety of social and medical needs.
Contact: David Feuerherd
df@issuesmanagement.com
310-215-0234
(LA BioMed)Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Visit our cancer / oncology section for the latest news on this subject.
MLA
24 May. 2012. <http://www.medicalnewstoday.com/releases/14202.php>
APA
http://www.medicalnewstoday.com/releases/14202.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Stage IV cancer patients and psilocybin - Patient Interviews'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
